Korea United Pharm Inc banner

Korea United Pharm Inc
KRX:033270

Watchlist Manager
Korea United Pharm Inc Logo
Korea United Pharm Inc
KRX:033270
Watchlist
Price: 20 300 KRW -1.69%
Market Cap: ₩298.6B

Korea United Pharm Inc
Other

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Korea United Pharm Inc
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
Korea United Pharm Inc
KRX:033270
Other
-₩25m
CAGR 3-Years
N/A
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Other
-₩3B
CAGR 3-Years
-265%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SK Biopharmaceuticals Co Ltd
KRX:326030
Other
₩0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Other
₩1.1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Other
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Caregen Co Ltd
KOSDAQ:214370
Other
₩200m
CAGR 3-Years
-30%
CAGR 5-Years
15%
CAGR 10-Years
N/A
No Stocks Found

Korea United Pharm Inc
Glance View

Market Cap
298.6B KRW
Industry
Pharmaceuticals

KOREA UNITED PHARM, Inc. engages in the manufacture and distribution of pharmaceuticals and healthcare products. The company is headquartered in Sejong, Sejong and currently employs 885 full-time employees. The company went IPO on 2007-10-23. INC. is a Korea-based company engaged in the manufacture and marketing of pharmaceuticals. The Company’s products include remedies for gastrointestinal system, cardiovascular, hematopoietic system, respiratory system, central nervous system, musculoskeletal system, endocrine and metabolic system, allergy and immune system, as well as anti-infectives, gynecological agents, vitamins, nutrition products, anticancer medicines and others. The company also provides active pharmaceutical ingredients (APIs) and various health food products. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
21 696.02 KRW
Undervaluation 6%
Intrinsic Value
Price

See Also

What is Korea United Pharm Inc's Other?
Other
-25m KRW

Based on the financial report for Sep 30, 2025, Korea United Pharm Inc's Other amounts to -25m KRW.

What is Korea United Pharm Inc's Other growth rate?
Other CAGR 5Y
-7%

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett